Detalhe da pesquisa
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
2.
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
BMC Cancer
; 24(1): 446, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600471
3.
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Br J Cancer
; 126(6): 874-880, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937947
4.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
N Engl J Med
; 381(17): 1632-1643, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566309
5.
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
Mol Cell Proteomics
; 19(4): 690-700, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107283
6.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Oncologist
; 25(3): e451-e459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162804
7.
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
Br J Cancer
; 121(5): 429-430, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350526
8.
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
Br J Cancer
; 120(2): 183-189, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30531832
9.
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Oncologist
; 23(11): 1271-e128, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120161
10.
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project.
Blood Cells Mol Dis
; 68: 173-179, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836529
11.
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Pharmacol Res
; 136: 133-139, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213564
12.
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
BMC Cancer
; 17(1): 798, 2017 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29183279
13.
Identification of new SNPs associated with severe toxicity to capecitabine.
Pharmacol Res
; 120: 133-137, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28347776
14.
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.
Future Oncol
; 13(23): 2065-2082, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28703622
15.
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular ß-glucosidases.
J Lipid Res
; 57(3): 451-63, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26724485
16.
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders.
Mol Genet Metab
; 117(2): 186-93, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26750750
17.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25877855
18.
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
BMC Cancer
; 15: 495, 2015 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26138480
19.
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
BMC Cancer
; 15: 327, 2015 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925749
20.
The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status.
Angiogenesis
; 17(4): 805-21, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24793846